Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""neutralizing antibody"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 105698
Tytuł:
Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials.
Autorzy:
Wang H; Genecradle Therapeutics Inc., Beijing 100176, China.
Zhang C; Genecradle Therapeutics Inc., Beijing 100176, China.
Dong Z; Beijing FivePlus Gene Technology Co., Ltd., Beijing 102629, China.
Zhu X; Genecradle Therapeutics Inc., Beijing 100176, China.
Zheng X; Genecradle Therapeutics Inc., Beijing 100176, China.
Liu Z; Genecradle Therapeutics Inc., Beijing 100176, China.
Zhou J; Genecradle Therapeutics Inc., Beijing 100176, China.
Yu S; Genecradle Therapeutics Inc., Beijing 100176, China.
Wu X; Genecradle Therapeutics Inc., Beijing 100176, China.
Dong X; Genecradle Therapeutics Inc., Beijing 100176, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 05; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
Glycogen Storage Disease Type II*/therapy
Animals ; Mice ; Humans ; Genetic Therapy ; Liver ; Disease Models, Animal ; Dependovirus/genetics ; Genetic Vectors/genetics ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata.
Autorzy:
Zheng M; Epi Biotech Co., Ltd., Incheon 21983, Republic of Korea.
Kim MH; Epi Biotech Co., Ltd., Incheon 21983, Republic of Korea.
Park SG; College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
Kim WS; Department of Dermatology, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Seoul 03181, Republic of Korea.
Oh SH; Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Sung JH; Epi Biotech Co., Ltd., Incheon 21983, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 30; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Alopecia Areata*/drug therapy
Alopecia Areata*/metabolism
Antibodies, Neutralizing*/pharmacology
Antibodies, Neutralizing*/metabolism
Animals ; Mice ; Alopecia/metabolism ; Androgens/metabolism ; Hair ; Hair Follicle/metabolism ; Skin/metabolism ; Chemokine CXCL12/immunology
SCR Disease Name:
Diffuse alopecia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neutralizing Antibody Response to Genotypically Diverse Measles Viruses in Clinically Suspected Measles Cases.
Autorzy:
Vaidya SR; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Kumbhar NS; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Andhare GK; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Pawar N; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Walimbe AM; ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
Kinikar M; Bioinformatics Centre, Savitribai Phule Pune University, Pune 411007, India.
Kasibhatla SM; Bioinformatics Centre, Savitribai Phule Pune University, Pune 411007, India.; HPC-Medical and Bioinformatics Applications Group, Centre for Development of Advanced Computing, Panchavati, Pashan, Pune 411008, India.
Kulkarni-Kale U; Bioinformatics Centre, Savitribai Phule Pune University, Pune 411007, India.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Nov 10; Vol. 15 (11). Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
Measles*
Humans ; Antibodies, Viral ; Neutralization Tests ; Measles virus/genetics ; Measles Vaccine ; Epitopes ; Immunoglobulin M
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
Autorzy:
Clairon Q; Université de Bordeaux, Inria Bordeaux Sud-Ouest, Bordeaux, France.; Inserm, Bordeaux Population Health Research Center, SISTM Team, UMR1219, Bordeaux, France.; Vaccine Research Institute, Créteil, France.
Prague M; Université de Bordeaux, Inria Bordeaux Sud-Ouest, Bordeaux, France.; Inserm, Bordeaux Population Health Research Center, SISTM Team, UMR1219, Bordeaux, France.; Vaccine Research Institute, Créteil, France.
Planas D; Vaccine Research Institute, Créteil, France.; Virus and Immunity Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR3569, Paris, France.
Bruel T; Vaccine Research Institute, Créteil, France.; Virus and Immunity Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR3569, Paris, France.
Hocqueloux L; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Régional, Orléans, France.
Prazuck T; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Régional, Orléans, France.
Schwartz O; Vaccine Research Institute, Créteil, France.; Virus and Immunity Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR3569, Paris, France.
Thiébaut R; Université de Bordeaux, Inria Bordeaux Sud-Ouest, Bordeaux, France.; Inserm, Bordeaux Population Health Research Center, SISTM Team, UMR1219, Bordeaux, France.; Vaccine Research Institute, Créteil, France.
Guedj J; Université Paris Cité, IAME, Inserm, Paris, France.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Aug 07; Vol. 19 (8), pp. e1011282. Date of Electronic Publication: 2023 Aug 07 (Print Publication: 2023).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*/prevention & control
Humans ; Antibodies, Viral ; BNT162 Vaccine ; Immunoglobulin G ; SARS-CoV-2/genetics ; Vaccination
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2.
Autorzy:
Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. .
Matsuda K; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.; Japan Foundation for AIDS Prevention, Tokyo, Japan.; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Maeda K; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Oshiro Y; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
Inamura N; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. .
Konishi M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Takeuchi JS; Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Horii K; Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
Ozeki M; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
Sugiyama H; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
Mitsuya H; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 May 04; Vol. 23 (1), pp. 282. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
Epidemics*
Humans ; BNT162 Vaccine ; Breakthrough Infections ; Vaccination ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acute muscle mass loss was alleviated with HMGB1 neutralizing antibody treatment in severe burned rats.
Autorzy:
Song J; Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA. .
Chowdhury IH; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Choudhuri S; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Ayadi AEI; Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA.
Rios LE; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Wolf SE; Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA.
Wenke JC; Department of Orthopedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX, USA.
Garg NJ; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. .; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 24; Vol. 13 (1), pp. 10250. Date of Electronic Publication: 2023 Jun 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Burns*/metabolism
Burns*/therapy
HMGB1 Protein*
Antibodies, Neutralizing*/therapeutic use
Animals ; Rats ; Inflammation/metabolism ; Muscle, Skeletal/metabolism ; Rats, Sprague-Dawley ; T-Lymphocytes/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal and Cross-Sectional Evaluation of Two Commercial Swine Breeding Herds to Characterize Neutralizing Antibody Levels following Porcine Epidemic Diarrhea Virus Outbreaks.
Autorzy:
Brown, Justin (AUTHOR)
Skoland, Kristin (AUTHOR)
Kittrell, Heather (AUTHOR)
Ellingson, Josh (AUTHOR)
Thomas, Paul (AUTHOR)
Ruston, Chelsea (AUTHOR)
Baum, David (AUTHOR)
Karriker, Locke (AUTHOR)
Pokaż więcej
Źródło:
Viruses (1999-4915). Mar024, Vol. 16 Issue 3, p324. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Production of neutralizing antibody fragment variants in the cytoplasm of E. coli for rapid screening: SARS-CoV-2 a case study.
Autorzy:
Tungekar AA; Protein and Structural Biology Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, 90220, Oulu, Finland.
Recacha R; Protein and Structural Biology Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, 90220, Oulu, Finland.; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.
Ruddock LW; Protein and Structural Biology Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, 90220, Oulu, Finland. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Mar 16; Vol. 13 (1), pp. 4408. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*
Humans ; SARS-CoV-2 ; Escherichia coli/metabolism ; Antibodies, Viral ; Cytoplasm/metabolism
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
Autorzy:
De Novellis, DaniloAff1, Aff2
Folliero, VeronicaAff1, Aff3
Giudice, ValentinaAff1, Aff2
Pezzullo, Luca
Sanna, Giuseppina
Fontana, Raffaele
Guariglia, Roberto
Zannella, Carla
Mettivier, Laura
Ferrara, Idalucia
Boccia, Giovanni
Buonanno, Maria Teresa
Martorelli, Maria Carmen
Luponio, Serena
Crudele, Andrea
Pagliano, Pasquale
Sessa, Anna Maria
Velino, Francesca
Langella, Maddalena
Manzin, Aldo
Galdiero, Massimiliano
Selleri, CarmineAff1, Aff2, IDs1023802301223w_cor22
Franci, GianluigiAff1, Aff3, IDs1023802301223w_cor23
Serio, BiancaAff1, Aff2, IDs1023802301223w_cor24
Pokaż więcej
Źródło:
Clinical and Experimental Medicine. 23(8):4943-4953
Czasopismo naukowe
Szczegóły
Tytuł:
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
Autorzy:
Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
Mahmoudjafari Z; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; University of Kansas Medical Center, Westwood, Kansas, USA.
Atieh T; University of Kansas Medical Center, Westwood, Kansas, USA.
Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
Cui W; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; University of Kansas Medical Center, Westwood, Kansas, USA.
Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
Mohan M; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA.
Remker C; University of Kansas Medical Center, Westwood, Kansas, USA.
Foss M; University of Kansas Medical Center, Westwood, Kansas, USA.
Karloff E; University of Kansas Medical Center, Westwood, Kansas, USA.
Fitch H; University of Kansas Medical Center, Westwood, Kansas, USA.
Atrash S; US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2022 Nov; Vol. 109 (5), pp. 458-464. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Neutralizing*
COVID-19*/prevention & control
Adult ; Antibodies, Viral ; BNT162 Vaccine ; COVID-19 Vaccines ; Humans ; Immunoglobulin G ; Neutralization Tests ; Plasma Cells ; Prospective Studies ; RNA, Messenger ; Retrospective Studies ; SARS-CoV-2 ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy
Autorzy:
Cosan, FulyaAff1, IDs4192702300342x_cor1
Demirel, Ozlem Unay
Yalcin, Demet
Sonkaya, Muhammed Mert
Uluisik, Isilsu Ezgi
Cecen, Olida
Furuncuoglu, Yavuz
Celikmen, Deniz Maktav
Kara, Osman
Ceylan, Erkan
Avsar, Timucin
Pokaż więcej
Źródło:
BMC Rheumatology. 7(1)
Czasopismo naukowe
Szczegóły
Tytuł:
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.
Autorzy:
Cheng, Samuel M.S. (AUTHOR)
Mok, Chris K.P. (AUTHOR)
Li, John K.C. (AUTHOR)
Chan, Ken K.P. (AUTHOR)
Luk, Kristine S. (AUTHOR)
Lee, Ben H.W. (AUTHOR)
Gu, Haogao (AUTHOR)
Chan, Karl C.K. (AUTHOR)
Tsang, Leo C.H. (AUTHOR)
Yiu, Karen Y.S. (AUTHOR)
Ling, Ken K.C. (AUTHOR)
Tang, Yun Sang (AUTHOR)
Luk, Leo L.H. (AUTHOR)
Yu, Jennifer K.M. (AUTHOR)
Pekosz, Andrew (AUTHOR)
Webby, Richard J. (AUTHOR)
Cowling, Benjamin J. (AUTHOR)
Hui, David S.C. (AUTHOR)
Peiris, Malik (AUTHOR)
Pokaż więcej
Źródło:
Virology Journal. 3/21/2024, Vol. 21 Issue 1, p1-7. 7p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Structural Basis for the Immunogenicity of the C-Terminus of VP1 of Echovirus 3 Revealed by the Binding of a Neutralizing Antibody.
Autorzy:
Qi S; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.; Department of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
Fu W; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.; Department of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
Fan J; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Zhang L; National Health Commission of the People's Republic of China, Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing 210009, China.
Zheng B; National Health Commission of the People's Republic of China, Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing 210009, China.
Wang K; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Wang X; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.; Department of New Diseases, Changping Laboratory, Beijing 102206, China.
Zhu L; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Li X; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.; Department of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
Zhang Y; Department of New Diseases, Changping Laboratory, Beijing 102206, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Oct 22; Vol. 14 (11). Date of Electronic Publication: 2022 Oct 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing*
Enterovirus B, Human*
Humans ; Antibodies, Monoclonal ; Antibodies, Viral ; Serogroup
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 Pandemic
Autorzy:
Friedman, Stephen M.Aff1, IDs1090002201142z_cor1
Li, Jieliang
Thomas, Pauline
Gurumurthy, Manisha
Siderits, Richard
Nepomich, Anna
Lifshitz, Edward
Pokaż więcej
Źródło:
Journal of Community Health: The Publication for Health Promotion and Disease Prevention. 48(1):50-58
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 105698

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies